Pathstone Holdings LLC Acquires 732 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Pathstone Holdings LLC lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 3.1% in the third quarter, Holdings Channel reports. The fund owned 24,028 shares of the company’s stock after purchasing an additional 732 shares during the quarter. Pathstone Holdings LLC’s holdings in Henry Schein were worth $1,752,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. American Century Companies Inc. boosted its position in shares of Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after buying an additional 162,477 shares during the period. Nuance Investments LLC boosted its position in shares of Henry Schein by 6.2% during the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after buying an additional 108,143 shares during the period. Burgundy Asset Management Ltd. boosted its position in shares of Henry Schein by 1.0% during the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after buying an additional 16,476 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Henry Schein by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock valued at $104,764,000 after buying an additional 149,517 shares during the period. Finally, Clarkston Capital Partners LLC boosted its position in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after buying an additional 71,560 shares during the period. Institutional investors own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on HSIC. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. dropped their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Robert W. Baird lowered their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, UBS Group lowered their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Six research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $79.38.

Henry Schein Stock Up 0.5 %

Henry Schein stock opened at $77.66 on Thursday. The business has a fifty day moving average of $71.15 and a two-hundred day moving average of $69.78. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.68 billion, a P/E ratio of 31.80, a P/E/G ratio of 2.20 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.32 earnings per share. On average, analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.